Globeflex Capital’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-41,137
| Closed | -$625K | – | 471 |
|
2018
Q4 | $625K | Buy |
41,137
+11,200
| +37% | +$170K | 0.15% | 232 |
|
2018
Q3 | $599K | Buy |
29,937
+22,237
| +289% | +$445K | 0.12% | 271 |
|
2018
Q2 | $150K | Buy |
7,700
+1,200
| +18% | +$23.4K | 0.03% | 400 |
|
2018
Q1 | $131K | Sell |
6,500
-37
| -0.6% | -$746 | 0.03% | 394 |
|
2017
Q4 | $87K | Sell |
6,537
-8,840
| -57% | -$118K | 0.02% | 362 |
|
2017
Q3 | $284K | Buy |
15,377
+6,537
| +74% | +$121K | 0.08% | 270 |
|
2017
Q2 | $163K | Hold |
8,840
| – | – | 0.04% | 325 |
|
2017
Q1 | $199K | Hold |
8,840
| – | – | 0.05% | 364 |
|
2016
Q4 | $308K | Hold |
8,840
| – | – | 0.08% | 316 |
|
2016
Q3 | $217K | Hold |
8,840
| – | – | 0.05% | 335 |
|
2016
Q2 | $211K | Sell |
8,840
-11
| -0.1% | -$263 | 0.06% | 327 |
|
2016
Q1 | $207K | Hold |
8,851
| – | – | 0.06% | 317 |
|
2015
Q4 | $267K | Buy |
8,851
+5,424
| +158% | +$164K | 0.07% | 290 |
|
2015
Q3 | $136K | Sell |
3,427
-20,205
| -85% | -$802K | 0.03% | 392 |
|
2015
Q2 | $1.63M | Sell |
23,632
-14,836
| -39% | -$1.02M | 0.3% | 91 |
|
2015
Q1 | $2.1M | Sell |
38,468
-6,438
| -14% | -$352K | 0.4% | 67 |
|
2014
Q4 | $1.91M | Buy |
+44,906
| New | +$1.91M | 0.37% | 80 |
|
2014
Q3 | – | Sell |
-81
| Closed | -$1K | – | 688 |
|
2014
Q2 | $1K | Sell |
81
-19
| -19% | -$235 | ﹤0.01% | 551 |
|
2014
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 569 |
|
2013
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 472 |
|